* Clear performance measures or metrics can have significant impact in
increasing adoption rates.mcgraw-hill.

yogyakarta submission

The Symposium is just one part of a larger effort between PATH and
McGraw -Hill Construction to explore further how the user-community thinks
about technology and about who is having the greatest influencing innovation
in the nation's homes. Applicants must hold an M. Currently our research programs include four approaches to
modifying or halting the progression of the disease .

hcp iadis

Now, we need to move to the various players' motives and
practices," stated Dr. Not only did we see federal government leaders interested and
involved, but our attendees remained engaged and dedicated to the discussions
throughout the day, a sign that our industry has a real need to understand how
innovation adoption works.aging-institute. Two of these programs
are in collaboration with Wyeth , focused on immunologic approaches to
treating the disease.

momm surabaya

In a first
event of its kind, PATH and McGraw-Hill Construction were able to bring these
players together to begin the process of uncovering what information is out
there, and how can we find out more on how these groups think how in order to
ignite innovation in the housing industry. The
Corporation has more than 290 offices in 38 countries. Only research programs with lead compounds are
eligible. Target discovery and validation programs will not be accepted. The deadline
date for submission is October 14, 2005.

cist 2007

* Other research or data collection methods are necessary to produce
better insights into housing innovation barriers, motivation and
adoption mechanisms. at 301-588-9387 or
jnrivera@drintl .

About the Partnership for Advancing Technology in Housing (PATH)
PATH addresses the totality of institutional barriers to technological
change in the industry, but it also acknowledges the need to work with
industrial partners and within the existing industrial structure to effect
change.

Applications are available at http://www.S.

ubiquitous amman

McGraw-Hill Construction and the Partnership for Advancing Technology In
Housing (PATH) Announce Preliminary Results From Housing Innovation Symposium

WASHINGTON, McGraw-Hill Construction and the
Partnership for the Advancing Technology in Housing (PATH) today announced the
preliminary results from the Symposium on Market Data for Housing Innovation,
held last week to help set the research agenda on housing innovation for the
coming years.
It was no surprise that understanding consumers, their behaviors and their
motives topped the list of immediate requirements to spur innovation in
housing, though builders and product manufacturers also were determined to
play a critical role.
After a day of intense discussion , the invite-only audience of leaders
from industry, academia, government and private research organizations ,
presented the priorities for research on each key stakeholder group involved
in advancing innovative homebuilding: consumers, builders, and manufacturers.
Bernstein pointed out the importance to having high level government
support and the success of the program, "The reaction from the meeting was
phenomenal.org.

About Alzheimer's Disease

Over 16 million Americans suffer with Alzheimer's disease, mild cognitive
impairment, and age-related cognitive decline.7 million for 133 research programs
and conferences at leading academic institutions and biotechnology
companies worldwide.

cere hohenheim

"I think the results are on point," stated Harvey Bernstein, Vice
President of Industry Analytics + Alliances for McGraw-Hill Construction.

These conclusions emerged as the most critical research areas, and will be
integrated into a report that offers policy and implementation plan strategies
for government and industry to use when moving forward in developing their
research agendas."
The "Identifying Housing Research Needs" project will release a final
report summarizing the Symposium's results as well as delivery policy papers
and strategy recommendations in the fall . For
more information, visit http://www. This three-year program is
being made possible through a generous donation from Elan Pharmaceuticals,
Inc.

deadline wmute

From project and product information to industry news, trends and
forecasts, the Company provides industry players the tools, resources and
applications that help them save time, money, and energy, especially through
the new McGraw-Hill Construction Network(R).





Elan


For more information, contact ISOA Executive Director Howard Fillit, MD at
212-935-2402 or hfillit@aging -institute.

2007 collaborating

construction.

cist collaborating

"If
we're going to move new products and innovation into practice, we need to
understand better the characteristics and incentives that are important to the
consumers - - what makes them receptive to new products? And from there, how
do they get information? If we can make consumers aware of options and get
them to demand innovation, we can transform our industry . degree and be
affiliated with an academic or medical research institution or a
biotechnology company.

collaborating ubiquitous

* Intermediaries, such as suppliers, retailers, installers, appraisers,
realtors, and media play various, and perhaps critical, roles in
spurring innovation. Sales in 2005 were
$6. Through groundbreaking market research initiatives such as
those imposed here , we will identify the activities most likely to positively
impact innovation diffusion.D. Criteria for selection is based on the qualifications of
the scientific staff conducting the study, the merit and feasibility of the
proposed research and its relevance to drug discovery and development for
Alzheimer's disease, the excellence of the research environment including
the availability of working with a multidisciplinary research team, and the
likelihood of advancing the field. society over $100 billion annually, making it the third most
costly disease after heart disease and cancer .8 million to 14 million by 2050. Four drugs are currently in the market
that relieve patients of symptoms suffered from Alzheimer's.aging-institute.

nopember deadline

PRESS RELEASE Institute for the Study of Aging Invites Scientists to Apply for New Alzheimer's Drug Discovery Research Grant Program

The goal of the
research program is to facilitate the discovery and development of
effective therapies for Alzheimer's disease ., to enable individuals, foundations and corporations to
partner with the Institute in an effort to raise additional funds and award
more grants.org, or
call Howard Fillit, MD (Executive Director ) or Suzanne Grossberg (Director
of Development) at 212 935 2402. We are committed to making a difference in the lives of patients
and their families by dedicating ourselves to bringing innovations in
science to fill significant unmet medical needs that continue to exist
around the world.elan.

amman momm

"
The results delved deeper into specific kinds of information that needs to
be gathered:

* There are different ways consumers and builders value innovation, and
these need to be better understood.com. Since its founding as a private foundation by the Lauder
family in 1998, ISOA has awarded $22.

inssbruck momm

S. Power and Associates.

It is anticipated that four one-year grants will be awarded in the first
year of the program.

About the Institute for the Study of Aging (ISOA)

The Institute for the Study of Aging (ISOA) is a biomedical venture
philanthropy whose sole mission is to accelerate the discovery and
development of new drugs to prevent, treat and cure Alzheimer's disease and
related dementias.

amman deadline

"
David Engel, Director for Affordable Housing Research and Technology from
the Office of Policy Development and Research, U.com/.

About The McGraw-Hill Companies
Founded in 1888, The McGraw-Hill Companies is a leading global information
services provider meeting worldwide needs in the financial services, education
and business information markets through leading brands such as Standard +
Poor's, McGraw-Hill Education, BusinessWeek and J.
Funds may be used for advancing the development of lead compounds through
pre-clinical in-vitro and in-vivo evaluation including pharmacology,
toxicology, pharmacokinetics, formulation chemistry and the conduct of
pre-clinical proof of concept studies.

Elan Pharmaceuticals, Inc.com, or call Davia Temin at 212 588 8788.

hcp iadis

At the end of the day, however, through a consensus voting process, it was
understanding the consumer that rose to the top as most critical and necessary
to spur innovation. "We know that all of these groups innovate or help the innovation
process, but we need to know more about how and when this happens. Elan is a neuroscience-based biotechnology
company.

momm sheraton

It was suggested that because of the range of products,
it was critical for the end-users of innovative technology (from homeowners to
remodelers to builders) to be able to access a clearinghouse of product
information like McGraw -Hill Construction's Sweets Network for products.
For more information or to obtain the preliminary report, please contact
Jennifer Rivera, D+R International, Ltd.0 billion. Though this task is daunting , recent evaluations suggest that PATH and
other Federal programs have taken the correct first steps towards achieving
industry change.com. invites scientists from academia and the biotechnology
industry to apply for a new research grant program entitled Novel
Approaches to Drug Discovery for Alzheimer 's Disease. or Ph.
Selections will be made by December 31, 2005, and funding will be awarded
in January 2006. One of the programs that focuses on halting the
progression of the disease through humanized monoclonal antibodies is in
Phase II clinical trials. For additional information about the company,
please visit http://www.

wmute reval

"For a number of years, we focused on developing the innovative
technologies. Carlos Martin, one of the directors of the PATH
program. Elan shares trade on the New York, London and
Dublin Stock Exchanges.

nopember momm

S.

About McGraw-Hill Construction
McGraw-Hill Construction, part of The McGraw-Hill Companies (NYSE: MHP),
connects people, projects and products across the design and construction
industry.6 trillion global construction community. More news and updates are available on
http://www. We continue to be dedicated to developing treatment
alternatives for patients and caregivers suffering from Alzheimer's
disease.

nopember ubiquitous

The Institute for the Study of Aging
(ISOA), Ltd.org. Applications will be reviewed by
an independent Scientific Review Committee convened by ISOA and comprised
of leading experts in Alzheimer's drug discovery and development research.

amman biennial

cere deadline

Department of Housing and
Urban Studies, and David Rogers, Program Manager for the Building Technologies
Program, U. Additional information is available at
http: //www.

The Call For Papers category is a directory of
sites that are related to academic scholarships in
Management Information Systems, especially for
Call for Papers and Call for Chapters.

cere inssbruck

Backed by the power of
Engineering News-Record (ENR), Dodge, Sweets, Architectural Record, MyHouse,
and 12 regional publications, McGraw-Hill Construction serves more than one
million customers within the $4.D.PATHnet.D. Alzheimer's disease alone
costs U. As the baby boomers retire,
the number of people with Alzheimer's disease is expected to increase from
4. In 2004, the Lauder family established a public
charity, ISOA, Ltd.

2006 reval

The Consumer Is Determined to Play the Most Critical Role In Spurring Housing Innovation

com.

and funds from ISOA. For more information, visit http: //www.

amman momm

Department of Energy (DOE) highlighted the importance of the
meeting and its results as part of the innovation process. No drugs are
available to address the underlying degenerative process .

About Elan Pharmaceuticals, Inc. is a wholly owned subsidiary of Elan
Corporation, plc (NYSE: ELN).

collaborating cere

---

- - kjjkjk

Loading...

(Note: These pages use the Atlas Content Safeguard System (ACSS) and require that Javascript is enabled for viewing.)